Biologics for Severe Asthma: Treatment-Specific Effects Are Important in Choosing a Specific Agent-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biologics for Severe Asthma: Treatment-Specific Effects Are Important in Choosing a Specific Agent

Published:2019-05 Issue:5 Volume:7 Page:1379-1392
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Krings James G.,McGregor Mary Clare,Bacharier Leonard B.,Castro Mario

Funder

Vectura

Sanofi

National Institutes of Health

American Lung Association

PCORI)

AstraZeneca

Boeringer Ingelheim

Chiesi

GSK

Novartis

Sanofi-Aventis

Amgen

Ception

Cephalon

Teva

KaloBios

MedImmune

PCORI

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference131 articles.

1. Global asthma prevalence in adults: findings from the cross-sectional world health survey;To;BMC Public Health,2012

2. The global burden of asthma: executive summary of the GINA Dissemination Committee report;Masoli;Allergy,2004

3. Clinical review: severe asthma;Papiris;Crit Care,2002

4. Factors associated with the control of severe asthma;Hermosa;J Asthma,2010

5. Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthma;Luskin;J Allergy Clin Immunol Pract,2014

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Therapies in Outpatient Pulmonary Medicine;Medical Clinics of North America;2024-09

2. De l’asthme difficile à traiter à l’asthme sévère : palier 5;Revue des Maladies Respiratoires;2024-08

3. Achieving control of severe asthma with targeted therapy;PULMONOLOGIYA;2024-07-03

4. Geographic and economic influences on benralizumab prescribing for severe asthma in Japan;Scientific Reports;2024-07-02

5. Clinical Remission Criteria and Serum Levels of Type 2 Inflammation Mediators during 24 Weeks of Treatment with the Anti-IL-5 Drug Mepolizumab in Patients with T2-High Severe Asthma;Diagnostics;2024-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3